
Committee Composition
DIANTHUS THERAPEUTICS ANNOUNCES POSITIVE TOP-LINE PHASE 1 DATA AND DEBUTS TRADING ON NASDAQ AS DNTH
Director Name | Audit Committee | Compensation Committee | Nominating and Corporate Governance Committee | Science and Technology Committee |
---|---|---|---|---|
Lonnie Moulder Chairman of the Board | member of Audit Committee | member of Compensation Committee | member of Nominating and Corporate Governance Committee | |
Alison Lawton | chairperson of Nominating and Corporate Governance Committee | |||
Anne McGeorge | chairperson of Audit Committee | |||
Jonathan Violin, Ph.D. | member of Science and Technology Committee | |||
Lei Meng | member of Nominating and Corporate Governance Committee | member of Science and Technology Committee | ||
Paula Soteropoulos | member of Audit Committee | chairperson of Compensation Committee | ||
Tomas Kiselak | member of Compensation Committee | chairperson of Science and Technology Committee |
Legend
= Chairperson
= Member
= Chairman of the Board